- Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
- Zai Lab Announces Participation in November Investor Conferences
- Zai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7, 2023
- Zai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injection) in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in China
- Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patients with NTRK-positive TKI-pretreated advanced solid tumors in China
- Zai Lab Announces Participation in September Investor Conferences
- Zai Lab Announces Second Quarter 2023 Financial Results and Corporate Updates
More ▼
Key statistics
On Monday, Zai Lab Ltd (1ZLB:DUS) closed at 1.65, 54.21% above the 52 week low of 1.07 set on Apr 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.70 |
---|---|
High | 1.71 |
Low | 1.65 |
Bid | 1.77 |
Offer | 1.84 |
Previous close | 1.62 |
Average volume | 175.00 |
---|---|
Shares outstanding | 996.09m |
Free float | 900.78m |
P/E (TTM) | -- |
Market cap | 15.04bn HKD |
EPS (TTM) | -2.73 HKD |
Data delayed at least 15 minutes, as of Jul 22 2024 18:30 BST.
More ▼